|
83
|
274
|
4dfnA |
Crystal structure of spleen tyrosine kinase complexed with an adamantylpyrazine inhibitor |
|
105
|
336
|
4dh5A |
Room temperature x-ray structure of camp dependent protein kinase a catalytic subunit with high mg2+, adp, phosphate, and ip20 |
|
76
|
280
|
4cv9A |
Mps1 kinase with 3-aminopyridin-2-one inhibitors |
|
67
|
230
|
4df3A |
Crystal structure of aeropyrum pernix fibrillarin in complex with natively bound s-adenosyl-l-methionine at 1.7a |
|
89
|
342
|
4dinA |
Novel localization and quaternary structure of the pka ri beta holoenzyme |
|
92
|
307
|
4d9uA |
Rsk2 c-terminal kinase domain, (e)-tert-butyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate |
|
105
|
336
|
4dh8A |
Room temperature x-ray structure of camp dependent protein kinase a catalytic subunit with high mg2+, amp-pnp and ip20 |
|
82
|
266
|
4deaA |
Aurora a in complex with yl1-038-18 |
|
79
|
272
|
4d4sA |
Focal adhesion kinase catalytic domain |
|
63
|
282
|
4d28A |
Crystal structure of the kinase domain of cipk24/sos2 |
|
109
|
350
|
4dg2E |
Crystal structure of myristoylated wt catalytic subunit of camp-dependent protein kinase in complex with sp20 |
|
78
|
284
|
4ct2A |
Human pdk1-pkczeta kinase chimera |
|
76
|
265
|
4dedA |
Aurora a in complex with yl1-038-21 |
|
96
|
294
|
4dawA |
Crystal structure of pak1 kinase domain with the ruthenium phthalimide complex |
|
125
|
377
|
4da5A |
Choline kinase alpha acts through a double-displacement kinetic mechanism involving enzyme isomerisation, as determined through enzyme and inhibitor kinetics and structural biology |
|
89
|
296
|
4cztA |
Crystal structure of the kinase domain of cipk23 |
|
87
|
274
|
4dflA |
Crystal structure of spleen tyrosine kinase complexed with a sulfonamidopyrazine piperidine inhibitor |
|
74
|
274
|
4dbnA |
Crystal structure of the kinase domain of human b-raf with a [1,3]thiazolo[5,4-b]pyridine derivative |
|
105
|
337
|
4dg3E |
Crystal structure of r336a mutant of camp-dependent protein kinase with unphosphorylated turn motif. |
|
105
|
362
|
4crlA |
Crystal structure of human cdk8-cyclin c in complex with cortistatin a |
|
87
|
295
|
4degA |
Crystal structure of c-met in complex with triazolopyridazine inhibitor 2 |
|
72
|
263
|
4byiA |
Aurora a kinase bound to a highly selective imidazopyridine inhibitor |
|
95
|
292
|
4btjA |
Ttbk1 in complex with atp |
|
81
|
279
|
4c4eA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
105
|
338
|
4c36A |
Pka-s6k1 chimera with compound 15e (cct147581) bound |
|
77
|
264
|
4c3pA |
Structure of dephosphorylated aurora a (122-403) bound to tpx2 and amppcp |
|
145
|
454
|
4btfA |
Structure of mlkl |
|
80
|
299
|
4cfxA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
93
|
292
|
4btmA |
Ttbk1 in complex with inhibitor |
|
81
|
271
|
4c7tA |
Focal adhesion kinase catalytic domain in complex with a diarylamino- 1,3,5-triazine inhibitor |
|
94
|
308
|
4cnhA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 3-((1r)-1-(5-fluoro-2-methoxyphenyl)ethoxy)-5-(1-methyl-1h- 1,2,3-triazol-5-yl)pyridin-2-amine |
|
107
|
322
|
4c02A |
Crystal structure of human acvr1 (alk2) in complex with fkbp12.6 and dorsomorphin |
|
86
|
300
|
4cfwA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
77
|
262
|
4c3rA |
Structure of dephosphorylated aurora a (122-403) bound to amppcp |
|
101
|
544
|
4cffA |
Structure of full length human ampk in complex with a small molecule activator, a thienopyridone derivative (a-769662) |
|
69
|
291
|
4c0tA |
Candida albicans pkh kinase domain |
|
87
|
297
|
4cfmA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
93
|
290
|
4btkA |
Ttbk1 in complex with inhibitor |
|
106
|
340
|
4c34A |
Pka-s6k1 chimera with staurosporine bound |
|
77
|
279
|
4c4hA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
77
|
280
|
4c4gA |
Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase mps1 |
|
95
|
308
|
4cmtA |
Structure of the human anaplastic lymphoma kinase in complex with the inhibitor 3-((1r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2-yl)phenyl)ethoxy)- 5-(3-(methylsulfonyl)phenyl)pyridin-2-amine |
|
328
|
843
|
4aayA |
Crystal structure of the arsenite oxidase protein complex from rhizobium species strain nt-26 |
|
124
|
378
|
4cgaA |
Human choline kinase a1 in complex with compound 5 |
|
47
|
171
|
4bvuA |
Structure of shigella effector ospg in complex with host ubch5c- ubiquitin conjugate |
|
98
|
308
|
4cd0A |
Structure of l1196m mutant human anaplastic lymphoma kinase in complex with 2-(5-(6-amino-5-((r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2- yl)phenyl)ethoxy)pyridin-3-yl)-4-methylthiazol-2-yl)propane-1,2-diol |
|
88
|
301
|
4cfvA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
87
|
300
|
4cfnA |
Structure-based design of c8-substituted o6-cyclohexylmethoxyguanine cdk1 and 2 inhibitors. |
|
108
|
337
|
4c38A |
Pka-s6k1 chimera with compound 21e (cct239066) bound |
|
93
|
308
|
4ccbA |
Structure of the human anaplastic lymphoma kinase in complex with 3-((r)-1-(5-fluoro-2-(2h-1,2,3-triazol-2-yl)phenyl)ethoxy)-5-(5-methyl-1h- pyrazol-4-yl)pyridin-2-amine |
